28 results on '"Muriel, Alfonso"'
Search Results
2. Significado pronóstico de los diagnósticos alternativos a la TEP hallados en la tomografía computarizada de tórax de pacientes ingresados por agudización de EPOC: subanálisis predefinido del ensayo SLICE
- Author
-
Rodríguez, Carmen, Solier, Aurora, Marín, Marta, Tenes, Andrés, Durán, Diego, Retegui, Ana, Muriel, Alfonso, Otero, Remedios, Monreal, Manuel, and Jiménez, David
- Published
- 2022
- Full Text
- View/download PDF
3. Diferencias epidemiológicas y de mortalidad entre hombres y mujeres con infección por VIH en la cohorte CoRIS entre los años 2004 y 2014
- Author
-
Muñoz Hornero, Constanza, Muriel, Alfonso, Montero, Marta, Iribarren, José Antonio, Masía, Mar, Muñoz, Leopoldo, Sampériz, Gloria, Navarro, Gemma, Moreno, Santiago, and Pérez-Elías, María Jesús
- Published
- 2021
- Full Text
- View/download PDF
4. Una puntuación de riesgo genético predice recurrencias en pacientes jóvenes con infarto agudo de miocardio
- Author
-
Rincón, Luis M., Sanmartín, Marcelo, Alonso, Gonzalo L., Rodríguez, José Antonio, Muriel, Alfonso, Casas, Eduardo, Navarro, Miguel, Carbonell, Alejandra, Lázaro, Carla, Fernández, Sara, González, Paz, Rodríguez, Macarena, Jiménez-Mena, Manuel, Fernández-Golfín, Covadonga, Esteban, Amparo, García-Bermejo, María Laura, and Zamorano, José L.
- Published
- 2020
- Full Text
- View/download PDF
5. Prevalencia de la infección por el VHC en un área sanitaria de Madrid: el primer paso para la microeliminación
- Author
-
Martínez-Sanz, Javier, Muriel, Alfonso, Vivancos-Gallego, María Jesús, Galán, Juan Carlos, Romero, Beatriz, Rodríguez-Sagrado, Miguel Ángel, Uranga, Almudena, Pérez-Elías, Pilar, Barea, Rafael, Chamorro-Escobar, Clotilde, Herrero-Delgado, Margarita, and Pérez-Elías, María Jesús
- Published
- 2020
- Full Text
- View/download PDF
6. La tasa de filtrado glomerular estimada es un biomarcador precoz de la insuficiencia renal aguda asociada a la cirugía cardíaca
- Author
-
Candela-Toha, Ángel, Pardo, María Carmen, Pérez, Teresa, Muriel, Alfonso, and Zamora, Javier
- Published
- 2018
- Full Text
- View/download PDF
7. Determinación no invasiva del efecto de atorvastatina en la microvasculatura coronaria y la función endotelial periférica de pacientes dislipémicos
- Author
-
Tomás, Juan P., Moya, José L., Campuzano, Raquel, Barrios, Vivencio, Megías, Alicia, Ruiz, Soledad, Catalán, Paz, Alonso Recarte, Manuel, and Muriel, Alfonso
- Published
- 2004
- Full Text
- View/download PDF
8. Asociación de la disfunción endotelial y el grosor mediointimal carotídeo con los factores de riesgo coronario en pacientes sin evidencia clínica de aterosclerosis
- Author
-
Campuzano, Raquel, Moya, José L., García-Lledó, Alberto, Salido, Luisa, Guzmán, Gabriela, Tomas, Juan P., Catalán, Paz., Muriel, Alfonso, and Asín, Enrique
- Published
- 2003
- Full Text
- View/download PDF
9. Mortalidad en lista de espera para trasplante renal
- Author
-
Hernández, Domingo, Castro-de la Nuez, Pablo, Muriel, Alfonso, Ruiz-Esteban, Pedro, and Alonso, Manuel
- Subjects
Kidney transplantation ,Trasplante renal ,Lista de espera ,Mortalidad ,Waiting list ,Diálisis ,Comorbidity ,Riesgo competitivo ,Mortality ,Competing risk ,Comorbilidad ,Dialysis - Abstract
El trasplante renal (Tx) representa el tratamiento de elección para los pacientes con enfermedad renal crónica avanzada (ERC), pero la escasez de órganos disponibles para aquellos con gran comorbilidad puede incrementar significativamente la mortalidad en enfermos candidatos a Tx. Esto constituye un problema sanitario preocupante, dado el incremento de los pacientes incidentes y prevalentes con ERC, especialmente de aquellos con ERC secundaria a entidades de gran comorbilidad como la diabetes y la hipertensión arterial. Asimismo, este hecho puede incrementar el número de pacientes en lista de espera (LE) y disparar sus cifras de mortalidad. Por tanto, actualmente resulta pertinente identificar las causas de muerte y los factores de riesgo de mortalidad en esta población, conocer las barreras que limitan el acceso al Tx y aplicar modelos predictivos de mortalidad en aras de mejorar los resultados de estos enfermos en términos de supervivencia. En esta revisión sobre la mortalidad de los pacientes en LE se abordarán los siguientes aspectos: 1) la magnitud de este problema y la importancia de algunos datos epidemiológicos; 2) los factores de riesgo de mortalidad en estos enfermos y las barreras que existen para el acceso al Tx que pudieran incrementar la mortalidad en esta población; 3) evaluación del riesgo de muerte de los pacientes en diálisis a partir de la comorbilidad; y 4) valoración de la mortalidad en LE mediante análisis de regresión de riesgos competitivos y la generación de un modelo de riesgo compuesto, incluyendo la comorbilidad y otros factores urémicos. Renal transplantation (Tx) represents the treatment of choice for patients with advanced chronic kidney disease (ACKD), but the shortage of available organs for those with a high level of comorbidity can significantly increase mortality in patients who are candidates for Tx. This constitutes a worrying health care problem, given the increase in incident and prevalent patients with ACKD, and is especially concerning amongst those with ACKD that is secondary to conditions with a high level of comorbidity, such as diabetes or arterial hypertension. In addition, this can increase the number of patients on the waiting list (WL) and cause the rapid raising of mortality figures. Therefore, nowadays it is relevant to identify the causes of death and the mortality risk factors in this population, to know the barriers that limit access to Tx and to apply predictive mortality models, with the aim of improving survival rates from these illnesses. In this review on the mortality of the patients on the WL, the following aspects will be addressed: 1) the magnitude of this problem and the importance of certain epidemiological data; 2) the mortality risk factors in these patients and the barriers that exist against access to Tx, which could increase mortality rates amongst this population; 3) evaluation of the risk of death in patients on dialysis from comorbidity; 4) assessment of mortality on the WL, via regression analysis of competitive risks, and the generation of a compound risk model, which includes comorbidity and other uraemic factors.
- Published
- 2015
10. Estudios observacionales longitudinales y causalidad
- Author
-
Muriel, Alfonso, Hernández-Marrero, Domingo, and Abraira, Víctor
- Published
- 2012
11. Herramientas bayesianas e independencia
- Author
-
Zamora, Javier, Muriel, Alfonso, and Abraira, Víctor
- Published
- 2003
- Full Text
- View/download PDF
12. C-reactive Protein and Risk of Right Ventricular Dysfunction and Mortality in Patients With Acute Symptomatic Pulmonary Embolism.
- Author
-
Najarro M, Rodríguez C, Morillo R, Jara-Palomares L, Vinson DR, Muriel A, Álvarez-Mon M, Yusen RD, Bikdeli B, and Jimenez D
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Acute Disease, Cohort Studies, Biomarkers blood, Pulmonary Embolism mortality, Pulmonary Embolism blood, Pulmonary Embolism complications, Ventricular Dysfunction, Right blood, Ventricular Dysfunction, Right mortality, Ventricular Dysfunction, Right etiology, C-Reactive Protein analysis
- Abstract
Background: Right ventricle (RV) dysfunction increases the risk of death from pulmonary embolism (PE). C-reactive protein (CRP) might identify RV inflammation and dysfunction in patients with PE., Methods: This cohort study enrolled consecutive stable patients with acute PE between 2017 and 2023. We stratified patients by quartiles of CRP. We evaluated the association between CRP quartiles and the presence of RV dysfunction, and used multivariable models to assess for an association between CRP and the outcomes of all-cause and PE-specific mortality during the 30 days of follow-up after PE diagnosis., Results: The study included 633 stable patients with PE. Patients without RV dysfunction had significantly lower median (IQR) CRP levels compared with patients with RV dysfunction (n=509, 31.7 [10.0-76.4]mg/L vs n=124, 45.4 [16.0-111.4]mg/L; P=0.018). CRP showed a statistically significant positive association with the presence of RV dysfunction (P<0.01). On multivariable analysis, CRP level was not significantly associated with 30-day all-cause mortality (adjusted odds ratio [OR] per mg/L increment, 1.00; 95% CI, 1.00-1.01; P=0.095), but higher CRP was associated with significantly higher PE-related mortality (adjusted OR, 1.01; 95% CI, 1.00-1.01; P=0.026). Compared with patients in CRP quartile 1, patients in quartiles 2, 3, and 4 had a stepwise increase in the adjusted odds of 30-day all-cause death of 2.41 (P=0.148), 3.04 (P=0.062), and 3.15 (P=0.052), respectively., Conclusions: As an indicator of RV dysfunction, CRP may improve risk stratification algorithms for hemodynamically stable patients with acute symptomatic PE., (Copyright © 2024 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
13. Identification of Low-risk Patients With Acute Symptomatic Pulmonary Embolism.
- Author
-
Jiménez D, Bikdeli B, Rodríguez C, Muriel A, Ballaz A, Soler S, Schellong S, Gil-Díaz A, Skride A, Riera-Mestre A, and Monreal M
- Subjects
- Humans, Acute Disease, Risk Factors, Tomography, X-Ray Computed, Ambulatory Care, Prognosis, Risk Assessment, Severity of Illness Index, Retrospective Studies, Pulmonary Embolism diagnostic imaging, Pulmonary Embolism complications
- Abstract
Background: Identification of patients with acute symptomatic pulmonary embolism (PE) who are at low-risk for short-term complications to warrant outpatient care lacks clarity., Method: In order to identify patients at low-risk for 30-day all-cause and PE-related mortality, we used a cohort of haemodynamically stable patients from the RIETE registry to compare the false-negative rate of four strategies: the simplified Pulmonary Embolism Severity Index (sPESI); a modified (i.e., heart rate cutoff of 100beats/min) sPESI; and a combination of the original and the modified sPESI with computed tomography (CT)-assessed right ventricle (RV)/left ventricle (LV) ratio., Results: Overall, 137 of 3117 patients with acute PE (4.4%) died during the first month. Of these, 41 (1.3%) died from PE, and 96 (3.1%) died from other causes. The proportion of patients categorized as having low-risk was highest with the sPESI and lowest with the combination of a modified sPESI and CT-assessed RV/LV ratio (32.5% versus 16.5%; P<0.001). However, among patients identified as low-risk, the 30-day mortality rate was lowest with the combination of a modified sPESI and CT-assessed RV/LV ratio and highest with the sPESI (0.4% versus 1.0%; P=0.03). The 30-day PE-related mortality rates for patients designated as low-risk by the sPESI, the modified sPESI, and the combination of the original and modified sPESI with CT-assessed RV/LV ratio were 0.7%, 0.4%, 0.7%, and 0.2%, respectively., Conclusions: The combination of a negative modified sPESI with CT-assessed RV/LV ratio ≤1 identifies patients with acute PE who are at very low-risk for short-term mortality., (Copyright © 2023 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
14. Granulocyte-colony stimulating factor in acute-on-chronic liver failure: Systematic review and meta-analysis of randomized controlled trials.
- Author
-
Martin-Mateos R, González-Alonso R, Álvarez-Díaz N, Muriel A, Gaetano-Gil A, Donate Ortega J, López-Jerez A, Figueroa Tubio A, and Albillos A
- Subjects
- Child, Humans, Randomized Controlled Trials as Topic, Granulocyte Colony-Stimulating Factor therapeutic use, Granulocytes, Asia, Acute-On-Chronic Liver Failure drug therapy
- Abstract
Background and Aims: A dysfunctional immune response is key to the pathogenesis of acute-on-chronic liver failure (ACLF). It has been suggested that treatment with granulocyte colony-stimulating factor (G-CSF) increases survival in patients with ACLF by improving immune cell dysfunction and promoting liver regeneration. The aim of the study is to evaluate the survival benefit associated with G-CSF administration compared with standard medical therapy (SMT) in ACLF., Methods: Systematic review and meta-analysis of randomized controlled trials. The primary outcome was survival at 60-90 days. We searched Ovid Medline, EMBASE, and Cochrane Central Register of Controlled Trials from inception to August 2021. Manual searches of reference lists in relevant articles and conference proceedings were also included. The revised Cochrane risk-of-bias tool was used for quality and risk of bias assessment. Two independent investigators extracted the data, and disagreements were solved by a third collaborator., Results: The initial search identified 142 studies. Four randomized controlled trials were selected for quantitative analysis including 310 patients (154 G-CSF and 156 SMT). Significant heterogeneity was observed (I
2 =74%, Chi2 =11.57, p=0.009). G-CSF administration did not improve survival in patients with ACLF (random-effects model, risk ratio=0.64 [95% CI 0.39, 1.07]). However, when considering only the results from the studies performed in Asia, a significant decrease on mortality was observed (risk ratio=0.53 [95% CI 0.35, 0.81]). Severity scores (MELD and Child) and CD34+ peripheral cells mobilization did not significantly improve with G-CSF., Conclusion: In a systematic review and meta-analysis, G-CSF administration did not significantly improve overall survival compared to SMT in patients with ACLF. The beneficial effects observed in Asian studies, as opposed to the European region, suggest that specific populations may benefit from further research aiming to identify certain subgroups with favourable outcomes when using G-CSF., (Copyright © 2022 Elsevier España, S.L.U. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
15. Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
- Author
-
Rodríguez C, Solier A, Marín M, Tenes A, Durán D, Retegui A, Muriel A, Otero R, Monreal M, and Jiménez D
- Subjects
- Humans, Angiography methods, Prognosis, Pulmonary Disease, Chronic Obstructive diagnosis, Pulmonary Embolism complications
- Abstract
Background: Among patients hospitalized for an exacerbation of chronic obstructive pulmonary disease (COPD), the SLICE trial showed that the addition of an active diagnostic strategy for pulmonary embolism (PE) to usual care compared with usual care alone did not improve a composite set of health outcomes. The objective of this subanalysis was to determine the frequency and prognostic significance of findings on computed tomography pulmonary angiogram (CTPA) supporting an alternative diagnosis to PE., Methods: We analyzed all patients randomized to the intervention in the SLICE trial who received a CTPA that did not show PE. We used multivariable logistic regression to assess the independent association between findings supporting an alternative diagnosis to PE and a composite of readmission for COPD or death within 90 days after randomization., Results: Among the 746 patients who were randomized, this subanalysis included 175 patients in the intervention group who received a CTPA that did not show PE. Eighty-four (48.0%) patients had acute bronchial infection, 13 (7.4%) had lung cancer, 10 (5.7%) had congestive heart failure, 8 (4.6%), 18 (10.3%) had other diagnoses, and 42 (24.0%) had a normal CTPA. In multivariable analysis, findings supporting an alternative diagnosis to PE were not significantly associated with the primary outcome (odds ratio: 0.64; 95% confidence interval: 0.30-1.38; P=0.26)., Conclusions: Among patients hospitalized for an exacerbation of COPD, CTPA identified an alternative diagnosis in 76% of the patients. However, specific management of these patients was not associated with improved outcomes within 90 days after randomization., (Copyright © 2022 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
16. Long-term Effect of CPAP Treatment on Cardiovascular Events in Patients With Resistant Hypertension and Sleep Apnea. Data From the HIPARCO-2 Study.
- Author
-
Navarro-Soriano C, Martínez-García MA, Torres G, Barbé F, Sánchez-de-la-Torre M, Caballero-Eraso C, Lloberes P, Cambriles TD, Somoza M, Masa JF, González M, Mañas E, de la Peña M, García-Río F, Montserrat JM, Muriel A, Oscullo G, García-Ortega A, Posadas T, and Campos-Rodríguez F
- Subjects
- Continuous Positive Airway Pressure, Humans, Prospective Studies, Hypertension epidemiology, Sleep Apnea Syndromes, Sleep Apnea, Obstructive epidemiology
- Abstract
Background: There is some controversy about the effect of continuous positive airway pressure (CPAP) on the incidence of cardiovascular events (CVE). However, the incidence of CVE among patients with both obstructive sleep apnea (OSA) ans resistant hypertension (HR) has not been evaluated. Our objective was to analyze the long-term effect of CPAP treatment in patients with RH and OSA on the incidence of CVE., Methods: Multi-center, observational and prospective study of patients with moderate-severe OSA and RH. All the patients were followed up every 3-6 months and the CVE incidence was measured. Patients adherent to CPAP (at least 4h/day) were compared with those with not adherent or those who had not been prescribed CPAP., Results: Valid data were obtained from 163 patients with 64 CVE incidents. Treatment with CPAP was offered to 82%. After 58 months of follow-up, 58.3% of patients were adherent to CPAP. Patients not adherent to CPAP presented a non-significant increase in the total CVE incidence (HR:1.6; 95%CI: 0.96-2.7; p=0.07). A sensitivity analysis showed that patients not adherent to CPAP had a significant increase in the incidence of cerebrovascular events (HR: 3.1; CI95%: 1.07-15.1; p=0.041) and hypertensive crises (HR: 5.1; CI95%: 2.2-11.6; p=0.006), but the trend went in the opposite direction with respect to coronary events (HR: 0.22; CI95%: 0.05-1.02; p=0.053)., Conclusions: In patients with RH and moderate-severe OSA, an uneffective treatment with CPAP showed a trend toward an increase in the incidence of CVE (particularly neurovascular events and hypertensive crises) without any changes with respect to coronary events., (Copyright © 2021. Publicado por Elsevier España, S.L.U.)
- Published
- 2021
- Full Text
- View/download PDF
17. Colistimethate sodium and acute kidney injury: Incidence, risk factors, outcome and prognosis of renal function.
- Author
-
Pampa-Saico S, Pintado V, Muriel A, Caravaca-Fontan F, Yerovi-León E, Rojo-Sanchis A, Del Rey JM, Teresa Tenorio M, and Liaño F
- Subjects
- Acute Kidney Injury epidemiology, Acute Kidney Injury mortality, Acute Kidney Injury physiopathology, Adult, Aged, Colistin adverse effects, Creatinine blood, Female, Glomerular Filtration Rate, Humans, Incidence, Kidney drug effects, Kidney physiology, Logistic Models, Male, Middle Aged, Prognosis, Renal Insufficiency, Chronic chemically induced, Renal Insufficiency, Chronic epidemiology, Retrospective Studies, Risk Factors, Sepsis complications, Shock, Septic complications, Time Factors, Treatment Outcome, Acute Kidney Injury chemically induced, Anti-Bacterial Agents adverse effects, Colistin analogs & derivatives
- Abstract
Background: Colistimethate sodium (CMS) treatment has increased over the last years, being acute kidney injury (AKI) its main drug-related adverse event. Therefore, this study aimed to evaluate the incidence and risk factors associated with AKI, as well as identifying the factors that determine renal function (RF) outcomes at six months after discharge., Materials and Methods: This retrospective study included adult septic patients receiving intravenous CMS for at least 48h (January 2007-December 2014). AKI was assessed using KDIGO criteria. The glomerular filtration rate (GFR) was estimated by the 4-variable MDRD equation. Logistic and linear models were performed to evaluate the risk factors for AKI and chronic kidney disease (CKD)., Results: Among 126 patients treated with CMS; the incidence of AKI was 48.4%. Sepsis-severe sepsis (OR 8.07, P=0.001), sepsis-septic shock (OR 42.9, P<0.001), and serum creatinine (SCr) at admission (OR 6.20, P=0.009) were independent predictors. Eighty-four patients survived; the main factors for RF evolution at the 6-month follow-up was baseline eGFR (0.58, P<0.001) and at discharge (0.34, P<0.001). Fifty-six percent (34/61) of the patients that developed AKI survived. At six months, 32% had CKD., Conclusions: The development of AKI in septic patients with CMS treatment was associated with sepsis severity and SCr at admission. Baseline eGFR and eGFR at discharge were and important determinant of the RF at the 6-month follow-up. These predictors may assist in clinical decision making for this patient population., (Copyright © 2020 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
18. Buffered solutions versus 0.9% saline for resuscitation in critically ill adults and children.
- Author
-
Antequera Martín AM, Barea Mendoza JA, Muriel A, Sáez I, Chico-Fernández M, Estrada-Lorenzo JM, and Plana MN
- Subjects
- Adult, Child, Crystalloid Solutions, Humans, Resuscitation, Critical Illness therapy, Saline Solution
- Published
- 2020
19. A genetic risk score predicts recurrent events after myocardial infarction in young adults.
- Author
-
Rincón LM, Sanmartín M, Alonso GL, Rodríguez JA, Muriel A, Casas E, Navarro M, Carbonell A, Lázaro C, Fernández S, González P, Rodríguez M, Jiménez-Mena M, Fernández-Golfín C, Esteban A, García-Bermejo ML, and Zamorano JL
- Subjects
- Aged, Humans, Predictive Value of Tests, Prospective Studies, Risk Assessment, Risk Factors, Young Adult, Myocardial Infarction diagnosis, Myocardial Infarction epidemiology, Myocardial Infarction genetics
- Abstract
Introduction and Objectives: To evaluate whether a genetic risk score (GRS) improves prediction of recurrent events in young nondiabetic patients presenting with an acute myocardial infarction (AMI) and identifies a more aggressive form of atherosclerosis., Methods: We conducted a prospective study with consecutive nondiabetic patients aged <55 years presenting with AMI. We performed a genetic test, cardiac computed tomography, and analyzed several biomarkers. We studied the association of a GRS composed of 11 genetic variants and a primary composite endpoint (cardiovascular mortality, a recurrent event, and cardiac hospitalization)., Results: A total of 81 patients were studied and followed up for a median of 4.1 years. There were 24 recurrent cardiovascular events. Compared with the general population, study participants had a higher prevalence of 9 out of 11 risk alleles. The GRS was significantly associated with recurrent cardiovascular events, especially when baseline low-density lipoprotein cholesterol (LDL-C) levels were elevated. Compared with the low-risk GRS tertile, the multivariate-adjusted HR for recurrences was 10.2 (95%CI, 1.1-100.3; P=.04) for the intermediate-risk group and was 20.7 (2.4-181.0; P=.006) for the high-risk group when LDL-C was≥2.8mmol/L (≥ 110mg/dL). Inclusion of the GRS improved the C-statistic (ΔC-statistic=0.086), cNRI (continuous net reclassification improvement) (30%), and the IDI (integrated discrimination improvement) index (0.05). Cardiac computed tomography frequently detected coronary calcified atherosclerosis but had limited value for prediction of recurrences. No association was observed between metalloproteinases, GRS and recurrences., Conclusions: A multilocus GRS may identify individuals at increased risk of long-term recurrences among young nondiabetic patients with AMI and improve clinical risk stratification models, particularly among patients with high baseline LDL-C levels., (Copyright © 2019 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
20. Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014.
- Author
-
Muñoz Hornero C, Muriel A, Montero M, Iribarren JA, Masía M, Muñoz L, Sampériz G, Navarro G, Moreno S, and Pérez-Elías MJ
- Abstract
Introduction: This study sought to analyse differences in epidemiology and survival between women and men living with HIV in the CoRIS cohort and the course of their disease over a 10-year period., Methods: Variables of interest between women living with HIV and men living with HIV were compared. A trend analysis was performed using the Mantel-Haenszel test. Kaplan-Meier survival curves and a Cox regression analysis were used to study survival., Results: A total of 10,469 people were enrolled; of them, 1,742 (16.6%) were women. At the time of enrolment in the cohort, women living with HIV, compared to men living with HIV, had higher rates of transmission due to intravenous drug use (IDU), hepatitisC virus (HCV) coinfection, AIDS-stage disease and foreign origin. They also had a worse immunovirological status and a lower educational level. These differences were maintained in the trend study. Regarding age, the women included in the cohort were older whereas the men were younger. In the comparative analysis between women according to place of origin, we found that the group of Spanish women living with HIV featured older women with higher rates of IDU transmission and HCV coinfection, whereas the group of women living with HIV born outside of Spain featured women with higher rates of syphilis infection. There were no major differences in relation to other characteristics such as educational level or disease status. Although sex was not a determinant of survival, conditions more prevalent in women were determinants of survival., Conclusions: HIV-infected women presented at diagnosis with certain epidemiological and HIV-associated characteristics that made them more vulnerable. These trends became more marked or did not improve during the years of observation., (Copyright © 2020 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
21. Increased HIV infection in patients with stroke in Spain. A 16-year population-based study.
- Author
-
Monreal E, Gullón P, Pérez-Torre P, Escobar-Villalba A, Acebron F, Quereda Rodríguez-Navarro C, Sánchez-Ruano L, Fernández-Félix BM, Muriel A, Pérez-Elías MJ, Masjuan J, and Corral Í
- Subjects
- Humans, Retrospective Studies, Spain epidemiology, HIV Infections epidemiology, Stroke epidemiology
- Abstract
Introduction: An increased incidence of stroke in HIV-infected patients has already been reported, suggesting that HIV infection may be a cerebrovascular risk factor. The objective of this study was to assess temporal trends in the proportion of HIV infection among patients with stroke in Spain., Methods: Data were obtained from the minimum basic dataset (MBDS) of all patients hospitalized in Spain between 1997 and 2012 with a primary or secondary diagnosis of stroke. The annual proportion of HIV infection and time trends (stratifying by type of stroke and HIV stage) were calculated, and predictors of HIV infection and the social and economic impact of HIV-infected (HIV+) and non-infected (HIV-) patients were analyzed., Results: Of 857,371 patients hospitalized with an incident stroke, 2134 (0.25%) had HIV infection. A 2.5% year-on-year increase (OR 1.025, 95% CI 1.015-1.036, p<0.0001) of the proportion of HIV-infected patients was observed due to an increase in the asymptomatic stage of the infection (per year OR 1.077, 95% CI 1.057-1.097, p<0.0001), as the proportion of patients with AIDS remained stable. Factors independently associated with HIV infection and stroke were active smoking, stimulating drugs and hepatitis C virus (HCV) infection. A higher mortality rate, longer hospital stay and a higher cost per hospitalized patient was observed among HIV+ patients., Conclusions: From 1997 to 2012, there was an increase in the proportion of HIV infection among patients hospitalized with stroke irrespective of the classical vascular risk factors, reinforcing the role of HIV infection as a cerebrovascular risk factor., (Copyright © 2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
22. Estimated glomerular filtration rate is an early biomarker of cardiac surgery-associated acute kidney injury.
- Author
-
Candela-Toha Á, Pardo MC, Pérez T, Muriel A, and Zamora J
- Subjects
- Acute Kidney Injury blood, Acute Kidney Injury urine, Aged, Biomarkers blood, Biomarkers urine, Female, Humans, Male, Postoperative Complications blood, Postoperative Complications urine, Predictive Value of Tests, Retrospective Studies, Time Factors, Acute Kidney Injury diagnosis, Cardiac Surgical Procedures, Glomerular Filtration Rate, Postoperative Complications diagnosis
- Abstract
Background: and objective Acute kidney injury (AKI) diagnosis is still based on serum creatinine and diuresis. However, increases in creatinine are typically delayed 48h or longer after injury. Our aim was to determine the utility of routine postoperative renal function blood tests, to predict AKI one or 2days in advance in a cohort of cardiac surgery patients., Patients and Methods: Using a prospective database, we selected a sample of patients who had undergone major cardiac surgery between January 2002 and December 2013. The ability of the parameters to predict AKI was based on Acute Kidney Injury Network serum creatinine criteria. A cohort of 3,962 cases was divided into 2groups of similar size, one being exploratory and the other a validation sample. The exploratory group was used to show primary objectives and the validation group to confirm results. The ability to predict AKI of several kidney function parameters measured in routine postoperative blood tests, was measured with time-dependent ROC curves. The primary endpoint was time from measurement to AKI diagnosis., Results: AKI developed in 610 (30.8%) and 623 (31.4%) patients in the exploratory and validation samples, respectively. Estimated glomerular filtration rate using the MDRD-4 equation showed the best AKI prediction capacity, with values for the AUC ROC curves between 0.700 and 0.946. We obtained different cut-off values for estimated glomerular filtration rate depending on the degree of AKI severity and on the time elapsed between surgery and parameter measurement. Results were confirmed in the validation sample., Conclusions: Postoperative estimated glomerular filtration rate using the MDRD-4 equation showed good ability to predict AKI following cardiac surgery one or 2days in advance., (Copyright © 2018 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
23. Mortality on a renal transplantation waiting list.
- Author
-
Hernández D, Castro-de la Nuez P, Muriel A, Ruiz-Esteban P, and Alonso M
- Subjects
- Cause of Death, Comorbidity, Follow-Up Studies, Health Services Accessibility, Humans, Models, Theoretical, Risk Assessment, Risk Factors, Kidney Failure, Chronic mortality, Kidney Transplantation, Waiting Lists
- Abstract
Renal transplantation (Tx) represents the treatment of choice for patients with advanced chronic kidney disease (ACKD), but the shortage of available organs for those with a high level of comorbidity can significantly increase mortality in patients who are candidates for Tx. This constitutes a worrying health care problem, given the increase in incident and prevalent patients with ACKD, and is especially concerning amongst those with ACKD that is secondary to conditions with a high level of comorbidity, such as diabetes or arterial hypertension. In addition, this can increase the number of patients on the waiting list (WL) and cause the rapid raising of mortality figures. Therefore, nowadays it is relevant to identify the causes of death and the mortality risk factors in this population, to know the barriers that limit access to Tx and to apply predictive mortality models, with the aim of improving survival rates from these illnesses. In this review on the mortality of the patients on the WL, the following aspects will be addressed: 1) the magnitude of this problem and the importance of certain epidemiological data; 2) the mortality risk factors in these patients and the barriers that exist against access to Tx, which could increase mortality rates amongst this population; 3) evaluation of the risk of death in patients on dialysis from comorbidity; 4) assessment of mortality on the WL, via regression analysis of competitive risks, and the generation of a compound risk model, which includes comorbidity and other uraemic factors.
- Published
- 2015
- Full Text
- View/download PDF
24. Longitudinal observational studies and causality.
- Author
-
Muriel A, Hernández-Marrero D, and Abraira V
- Subjects
- Humans, Causality, Longitudinal Studies standards
- Published
- 2012
- Full Text
- View/download PDF
25. [Does hypothermic machine perfusion provide an advantage over cold storage in the incidence rate of delayed graft function following a deceased-donor kidney transplant?].
- Author
-
Muriel A, López V, Zamora Vincente J, Gutiérrez C, Abraira Santos V, and Hernández Marrero D
- Published
- 2009
- Full Text
- View/download PDF
26. [Noninvasive assessment of the effect of atorvastatin on coronary microvasculature and endothelial function in patients with dyslipidemia].
- Author
-
Tomás JP, Moya JL, Campuzano R, Barrios V, Megías A, Ruiz S, Catalán P, Recarte MA, and Muriel A
- Subjects
- Aged, Atorvastatin, Cholesterol blood, Cholesterol, HDL blood, Cholesterol, LDL blood, Data Interpretation, Statistical, Echocardiography, Endothelium, Vascular physiology, Female, Heptanoic Acids administration & dosage, Heptanoic Acids therapeutic use, Humans, Hyperlipidemias blood, Hyperlipidemias drug therapy, Male, Middle Aged, Models, Theoretical, Pyrroles administration & dosage, Pyrroles therapeutic use, Time Factors, Triglycerides blood, Vasodilation physiology, Coronary Circulation drug effects, Endothelium, Vascular drug effects, Heptanoic Acids pharmacology, Microcirculation drug effects, Pyrroles pharmacology
- Abstract
Introduction and Objectives: The effect of statins has been monitored mainly in peripheral arteries. It is now possible to study coronary microcirculation by analyzing coronary reserve with transthoracic echocardiography. The aim of this study was to use this noninvasive technique to evaluate the effect of atorvastatin on peripheral endothelial function and on the coronary microvasculature in patients with dyslipidemia., Patients and Method: We included 21 patients with dyslipidemia but no clinical antecedents of atherosclerosis. Mean (SD) age was 64.9 (11) years, and women made up 61.9% of the group. All patients were treated with 20 mg atorvastatin during 3 months. Lipid profile, carotid intima-media thickness, endothelium-dependent vasodilation and coronary flow reserve were determined at baseline and at the end of treatment. All studies were performed with echocardiographic techniques., Results: Together with improvements in the lipid profile, we found a 43% increase in endothelium-dependent vasodilation (4.3 [4.4] to 6.2 [3.8]; P=.07) and a 25% increase in coronary flow reserve (2.5 [0.6] vs 3.1 [0.8]; P=.002). The increase in endothelium-dependent vasodilatation correlated with age (r=-0.60; P=.004), intima-media thickness (r=-0.47; P=.029), low-density lipoprotein level before treatment (r=-0.43; P=.05), and baseline endothelium-dependent vasodilatation (r=-0.63; P=.002). The increase in coronary flow reserve correlated with low-density lipoprotein level after treatment (r=-0.51; P=.04)., Conclusions: Short-term treatment with atorvastatin improved the lipid profile, coronary microvascular function and endothelium-dependent vasodilation in the peripheral circulation. The noninvasive assessment of coronary reserve is feasible with transthoracic echocardiography.
- Published
- 2004
27. [Endothelial dysfunction and intima-media thickness in relation to cardiovascular risk factors in patients without clinical manifestations of atherosclerosis].
- Author
-
Campuzano R, Moya JL, García-Lledó A, Salido L, Guzmán G, Tomas JP, Catalán P, Muriel A, and Asín E
- Subjects
- Aged, Arteriosclerosis complications, Arteriosclerosis drug therapy, Female, Humans, Male, Middle Aged, Nitroglycerin administration & dosage, Nitroglycerin therapeutic use, Risk Factors, Vasodilator Agents administration & dosage, Vasodilator Agents therapeutic use, Arteriosclerosis physiopathology, Cardiovascular Diseases physiopathology, Endothelium, Vascular physiopathology
- Abstract
Introduction: Endothelial dysfunction and increased intima-media thickness are early findings in the development of atherosclerosis that can be assessed non-invasively by echography. The aim of this study was to investigate endothelial function and intima-media thickness, and the relation between these processes and cardiovascular risk factors in patients without clinical atherosclerosis., Patients and Method: Fifty-two subjects were studied, 39 with one or more cardiovascular risk factors and 13 with none. Vascular echography was performed to analyze endothelium-dependent vascular dilatation in the brachial artery and intima-media thickness in the common carotid artery., Results: Compared to patients without risk factors, patients with cardiovascular risk factors more frequently had impaired vascular dilatation after ischemia, 11.98 4.61% vs 2.77 2.57%, (P<.0.001; mean difference = 9.21%, 95% CI of the difference 6.33-12.07%) and a greater intima-media thickness, 0.085 0.024% vs 0.057 0.014 cm (P < 0.0001; mean difference = 0.028 cm, 95% CI of the difference, 0.017-0.04 cm). There was a significant negative correlation between intimal-media thickness and endothelial dysfunction (r = -0.357; P<0.01). Linear regression analysis showed that intima-media thickness was independently related to age and the presence of hypertension, while endothelial function was related only with the presence of hypertension, smoking, and hyperlipoproteinemia., Conclusions: In patients without clinical atherosclerotic disease, cardiovascular risk factors were associated with impaired endothelial function and increased intima-media thickness. There was a negative correlation between endothelial-dependent vascular dilatation and intima-media thickness.
- Published
- 2003
- Full Text
- View/download PDF
28. [Bayesian tools and independence].
- Author
-
Zamora J, Muriel A, and Abraira V
- Subjects
- Bayes Theorem
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.